National Center for Tumor Diseases, Heidelberg
30
4
5
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
20.0%
6 terminated/withdrawn out of 30 trials
72.7%
-13.8% vs industry average
3%
1 trials in Phase 3/4
0%
0 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (30)
PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers
Role: collaborator
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
Role: collaborator
CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)
Role: collaborator
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
Role: collaborator
A Longitudinal Study to Investigate and Develop a Patient-centered and Effective Fatigue Screening
Role: collaborator
Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors
Role: lead
NCT Neuro Master Match - N²M² (NOA-20)
Role: collaborator
TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With Bortezomib
Role: collaborator
Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease
Role: collaborator
Preventing Sensory and Motor Dysfunctions in Children Receiving Neurotoxic Chemotherapy
Role: collaborator
Evaluation of the Effects of Whole Body Vibration on the Lung Function of Patients With Stable COPD
Role: collaborator
Decitabine Treatment in HPV-Induced Anogenital and Head and Neck Cancer Patients After Radiotherapy or as Novel Late Salvage
Role: collaborator
Prevention of Chemotherapy-Related Polyneuropathy Via Sensorimotor Exercise Training
Role: collaborator
Physical Exercise Therapy vs Relaxation in Allogeneic Stem Cell Transplantation (PETRA)
Role: collaborator
Study of Palbociclib in MLL-rearranged Acute Leukemias
Role: collaborator
Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas
Role: lead
POSITIVE - Study (Part III) Heidelberg
Role: collaborator
WES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data
Role: collaborator
Vorinostat in Children
Role: lead
Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer
Role: lead